| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8652851 | The Annals of Thoracic Surgery | 2018 | 7 Pages |
Abstract
The LivaNova Mitroflow valve appears to be prone to early deterioration. Smaller size prostheses should be used cautiously and avoided with patient-prosthesis mismatch. The DL model anticalcification treatment seems unable to prevent early degeneration, and possibly contributes to even earlier failure.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Carlo PhD, Valentina MD, Emanuele MD, Sonia PhD, Ilaria MD, Guglielmo MD, Marta MD, Dionisio F. MD, Antonio MD, Giovanni MD,